An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2025-04-16
DOI
https://doi.org/10.1016/j.ebiom.2025.105699
Citations
1
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19

Ruiqi Zhang, Wenlin Tai, Runhong Zhou, Ivan Fan‐Ngai Hung et al.
1 citations
EBioMedicine
SARS-CoV-2 and COVID-19 Research
1.40
article

An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19

Ruiqi Zhang, Wenlin Tai, Runhong Zhou, Ivan Fan‐Ngai Hung, Kin Fai Woo, Xia Jin, Ting Wang, Zhiwei Chen, Kai Pang, Wing Yin Cheng, Yanhua Du, Derek Hoi Hang Ho, Yik Chun Wong
article en
1 citations

Abstract

No abstract available for this paper.
EBioMedicineVol. 115
Hong Kong Science and Technology Parks Corporation (HK), University of Hong Kong (HK)
Good health and well-being
Openalex Percentile: Top 22%
SARS-CoV-2 and COVID-19 Research
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.